Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
University Health Network · University of Lübeck · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
254
total citations
- FWCI
- 49.13
- Percentile
- 100%
- References
- 31
Citations per year
Authors
291Topics & keywords
Topics
Keywords
- Myasthenia gravis
- Placebo
- Medicine
- Double blind
- Phase (matter)
- Physical medicine and rehabilitation
- Anesthesia
- Physical therapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.